On December 14th and 15th the Clinnova Consortium members met at the DKFZ in Heidelberg, Germany, for their second Consortium meeting. The main topics on the agenda were the further definition of the scientific strategy of the Centre of Excellence as well as the organizational model Clinnova could have in the future.
20 participants from the NCT, CIMT, LIH, the University of Luxembourg and FNR were involved in the fruitful discussions to help further cristalize the vision of what Clinnova would look like in the future. Building on existing excellence in Luxembourg in preclinical research and bioinformatics and data analytics, Clinnova will link to the excellence in translational cancer research at DKFZ as well as the expertise of the Odense University hospital of bringing advanced digital tools to patients. Data analytics and integration of data from different sources (clinical, molecular, mobile sensors etc) will be at the core of Clinnva. The clinical focus will be on chronic diseases of the nervous system, in particular multiple sclerosis, as well as on cancers, with a focus on brain and gastrointestinal cancers.
Consortium members also met with representatives of the BioRN Cluster as well as the BioMedX incubator to get inspired by the successful economic valorisation and the development of a prospering biotech ecosystem in the Heidelberg region.